Violation Tracker Individual Record
Date:June 4, 2014
Offense Group:competition-related offenses
Primary Offense:kickbacks and bribery
GlaxoSmithKline, LLC agreed to pay $105 million to resolve multistate litigation alleging that the company unlawfully promoted its asthma drug, Advair, and antidepressant drugs, Paxil and Wellbutrin.
Level of Government:state
Action Type:agency action
Agency:Multistate Attorneys General Case
Civil or Criminal Case:civil
HQ Country of Parent:United Kingdom
Ownership Structure of Parent:publicly traded
Major Industry of Parent:pharmaceuticals
Specific Industry of Parent:pharmaceuticals
Link to Archived Court Document:
Source Notes:If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.